Completed
A Phase 1 Study of AMV564 in Patients With Intermediate or High-Risk Myelodysplastic Syndromes
NCT03516591
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Washington University, Siteman Cancer Center St Louis, Missouri, United States
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States